Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Richard Grimm, DO, is Director of the Echocardiography Laboratory and a staff cardiologist in the Section of Cardiovascular Imaging, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute. He is board-certified in cardiovascular disease. Dr. Grimm is a Fellow of the American College of Cardiology and the American Society of Echocardiography. In addition to his primary specialty of general cardiology, Dr. Grimm has special interests in Echocardiography, Cardiac Computed Tomography, heart valve disease, cardiac resynchronization therapy for heart failure, atrial fibrillation and aortic disease.
An Ohio native, Dr. Grimm earned his medical degree from the Ohio University College of Osteopathic Medicine. He completed his clinical training with an internship at Doctors Hospital in Columbus, Ohio, where he was named "Intern of the Year." He served a residency in internal medicine at Cleveland Clinic, followed by fellowships in Cardiology and subsequently Cardiovascular Imaging. In 1994, he was appointed to Cleveland Clinic as a staff cardiologist and named to his current position as Director of Echocardiography in 2005.
Dr. Grimm has participated in a number of multi-center clinical trials, including serving as co-primary investigator in the ACUTE trial, which studied transesophageal echocardiography guidance in patients with atrial fibrillation undergoing cardioversion, as well as studies examining the utility of echocardiography in resynchronization therapy for patients with heart failure. He received the Cleveland Clinic Cardiology Research Award in 1993 and in 1994 was awarded an American Heart Association fellowship grant to study the pathophysiologic mechanisms of atrial fibrillation and thrombogenesis. In 2002, Dr Grimm was honored with the Distinguished Teacher Award by the Department of Cardiovascular Medicine, and in 2007 he was recognized with an Innovator Award by Cleveland Clinic Innovations. He is currently serving on the Board of Directors of the American Society of Echocardiography
He has served as an editorial reviewer for such leading publications as Circulation, the Journal of the American College of Cardiology, the Journal of the American Society of Echocardiography , the American Journal of Cardiology and Heart. Dr. Grimm is a frequent lecturer at national and international conferences and has published more than 200 manuscripts, book chapters and abstracts on his specialty interests. He is a member of the American College of Cardiology, the American Heart Association and the American Society of Echocardiography
Dr. Grimm was named to "Best Doctors in America" for 2007-2011 and "Best Doctors in Cleveland" for 2006-2011. In his leisure time, Dr. Grimm enjoys golfing, skiing and hiking.
Heart Valve Disease, Pericardial Disease, Thoracic Aortic Aneurysm, Cardiovascular Imaging, Echocardiography, Atrial Fibrillation, Optimizing Device Therapy (cardiac resynchronization therapy) for Heart Failure
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/21/2014, Dr. Grimm has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.